The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • The Calmer Co International (ASX:CCO) reports an increase in ecommerce sales for October
  • Global ecommerce sales for the month reached more than $190,000, up 42 per cent from the previous record high of $130,000 in September
  • Ecommerce sales in Australia exceeded $70,000 during October, a 82 per cent increase compared to September, and the US also showed growth, surpassing $120,000 for October, a 30 per cent increase from September
  • Daily global ecommerce sale rates have now exceeded $6000 and continue to grow
  • CCO last traded at 0.4 cents

The Calmer Co International (ASX:CCO) has reported an increase in its ecommerce sales performance for October.

The health and wellness company specialises in natural products designed to enhance calmness, support mental and muscle relaxation, and improve sleep.

“Ecommerce is our first growth pillar and has been the focus over the last six months, the solid foundation built with RooLife in Australia has now been taken forward by The Calmer Co team in October and the results in Australia are very promising, indeed, we continue to be the number one instant kava product on Amazon,” CCO CEO Anthony Noble said.

The company reported that global ecommerce sales for the month of October reached more than $190,000, marking a 42 per cent increase from the previous record high of $130,000 in September.

Ecommerce sales in Australia exceeded $70,000 in October, an 82 per cent increase compared to September, and the US also showed growth, surpassing $120,000 in October, a 30 per cent increase from September.

Daily global ecommerce sale rates have now exceeded $6000 and continue to grow across all channels.

Mr Noble credited the company’s growth to platforms like Amazon and its distribution in Coles Australia, which have contributed to building the company’s brand profile and consumer trust.

CCO last traded at 0.4 cents.

cco by the numbers
More From The Market Online

LTR Pharma’s SPONTAN investigation in pulmonary arterial hypertension approved

LTR Pharma has received approval for an investigator-initiated clinical study evaluating SPONTAN in patients with newly…

Wisr delivers record growth and upgrades FY27 guidance

Wisr has reported that its loan book reached $1.2 billion in Q1FY27, increasing 40% to $1,211…

Aquirian receives increased equipment funding facility from NAB to $25M

Aquirian has obtained approval from the National Australia Bank for an increase to the group’s master…
HotCopper Daily Market Trends Graphic

Thursday’s HotCopper trends: AXP Energy, Tambourah Metals, Santos and other daily topics

With more than 600k average monthly users on the HotCopper forums, each and every discussion can…